Goldman Sachs Group Inc Atri Cure, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 422,498 shares of ATRC stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
422,498
Previous 583,779 27.63%
Holding current value
$15.2 Million
Previous $13.3 Million 10.88%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$20.34 - $29.5 $3.28 Million - $4.76 Million
-161,281 Reduced 27.63%
422,498 $11.8 Million
Q2 2024

Aug 13, 2024
BUY
$19.86 - $29.09 $3.58 Million - $5.25 Million
180,379 Added 44.71%
583,779 $13.3 Million
Q1 2024

May 15, 2024
BUY
$28.21 - $37.78 $1.35 Million - $1.81 Million
47,799 Added 13.44%
403,400 $12.3 Million
Q4 2023

Feb 13, 2024
BUY
$32.99 - $43.25 $3.75 Million - $4.91 Million
113,543 Added 46.91%
355,601 $12.7 Million
Q3 2023

May 14, 2024
SELL
$41.12 - $57.73 $4.67 Million - $6.55 Million
-113,543 Reduced 31.93%
242,058 $10.6 Million
Q3 2023

Nov 14, 2023
SELL
$41.12 - $57.73 $816,067 - $1.15 Million
-19,846 Reduced 7.58%
242,058 $10.6 Million
Q2 2023

May 14, 2024
BUY
$40.44 - $49.6 $969,306 - $1.19 Million
23,969 Added 10.07%
261,904 $12.9 Million
Q2 2023

Aug 14, 2023
BUY
$40.44 - $49.6 $969,306 - $1.19 Million
23,969 Added 10.07%
261,904 $12.9 Million
Q1 2023

May 14, 2024
BUY
$35.87 - $47.22 $446,760 - $588,125
12,455 Added 5.52%
237,935 $9.86 Million
Q1 2023

May 11, 2023
BUY
$35.87 - $47.22 $446,760 - $588,125
12,455 Added 5.52%
237,935 $9.86 Million
Q4 2022

May 14, 2024
BUY
$33.48 - $47.45 $3.93 Million - $5.57 Million
117,476 Added 108.77%
225,480 $10 Million
Q4 2022

Feb 13, 2023
BUY
$33.48 - $47.45 $3.93 Million - $5.57 Million
117,476 Added 108.77%
225,480 $10 Million
Q3 2022

May 14, 2024
BUY
$38.25 - $52.62 $687,582 - $945,897
17,976 Added 19.97%
108,004 $4.22 Million
Q3 2022

Nov 10, 2022
BUY
$38.25 - $52.62 $687,582 - $945,897
17,976 Added 19.97%
108,004 $4.22 Million
Q2 2022

May 14, 2024
SELL
$35.1 - $66.01 $9.32 Million - $17.5 Million
-265,573 Reduced 74.68%
90,028 $3.68 Million
Q2 2022

Aug 15, 2022
BUY
$35.1 - $66.01 $1.07 Million - $2 Million
30,363 Added 50.89%
90,028 $3.68 Million
Q1 2022

May 16, 2022
BUY
$57.43 - $71.39 $209,045 - $259,859
3,640 Added 6.5%
59,665 $3.92 Million
Q4 2021

Feb 14, 2022
SELL
$63.4 - $87.14 $1.73 Million - $2.38 Million
-27,357 Reduced 32.81%
56,025 $3.9 Million
Q3 2021

Nov 10, 2021
BUY
$69.28 - $84.46 $5.78 Million - $7.04 Million
83,382 New
83,382 $5.8 Million

Others Institutions Holding ATRC

# of Institutions
212
Shares Held
49.7M
Call Options Held
12K
Put Options Held
7.2K
View Full List

About AtriCure, Inc.

ATRC Quotes by TradingView
  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.67B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email